| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
and BRL 49653 on Peroxisome Proliferator-Activated Receptor (PPAR)
2 Gene Expression and Other Adipocyte Genes
The USDA Human Nutrition Research Center on Aging at Tufts University and Division of Endocrinology Tupper Medical Research Institute New England Medical Center Boston, Massachusetts 02111
Expression of tumor necrosis factor-
(TNF
)
in adipocytes has been reported to correlate with insulin
resistance associated with obesity. The thiazolidinediones such as BRL
49653 have been reported to improve insulin sensitivity in obese
animals and humans. Although its exact mechanism of action is not
known, BRL 49653 has been shown to antagonize some of the inhibitory
actions of TNF
. BRL 49653 binds and activates the peroxisome
proliferator-activated receptor (PPAR
2), an important nuclear
transcription factor in adipocyte differentiation; however, its
regulation of PPAR
2 in differentiated adipocytes is unknown. In this
paper, we find that BRL 49653 blocked the ability of TNF
to
down-regulate the expression and transcription of several adipocyte
genes, but BRL 49653 did not prevent TNF
from down-regulating
PPAR
2. Moreover, BRL 49653 alone initially decreased the expression
of PPAR
2 mRNA and protein greatly. After 24 h of treatment in
3T3-L1 adipocytes, BRL 49653 down-regulated PPAR
2 by greater than
90% and potentiated the decrease of PPAR
2 mRNA by TNF
at this
time. These unexpected results prompted us to repeat the experiments
for a longer time to determine whether BRL 49653 would continue to
down-regulate PPAR
2. With prolonged BRL 49653 treatment, PPAR
2
mRNA expression was not decreased as greatly, and the protein levels
were decreased 2030% below control at 72 h compared to 90% at
24 h. Although BRL 49653 continued to prevent the inhibitory
effects of TNF
on perilipin and aP2 mRNA, by 72 h, BRL 49653
was not as potent an inhibitor of TNF
s down-regulation of
perilipin protein. Since PPAR
2 protein was more abundant at this
time, these results suggest that the level of PPAR
2 protein is not
the sole factor that regulates the transcriptional control by BRL
49653.
This article has been cited by other articles:
![]() |
D. L. Brasaemle Thematic review series: Adipocyte Biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis J. Lipid Res., December 1, 2007; 48(12): 2547 - 2559. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Jorgensen, D. Zadravec, and A. Jacobsson Norepinephrine and rosiglitazone synergistically induce Elovl3 expression in brown adipocytes Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1159 - E1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Kim, K. Tillison, J.-H. Lee, D. A. Rearick, and C. M. Smas The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-{alpha} in 3T3-L1 adipocytes and is a target for transactivation by PPAR{gamma} Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E115 - E127. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamaguchi, S. Matsushita, K. Motojima, F. Hirose, and T. Osumi MLDP, a Novel PAT Family Protein Localized to Lipid Droplets and Enriched in the Heart, Is Regulated by Peroxisome Proliferator-activated Receptor {alpha} J. Biol. Chem., May 19, 2006; 281(20): 14232 - 14240. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Schaffler and H Herfarth Creeping fat in Crohn's disease: travelling in a creeper lane of research? Gut, June 1, 2005; 54(6): 742 - 744. [Full Text] [PDF] |
||||
![]() |
E. Lord, S. Ledoux, B. D. Murphy, D. Beaudry, and M. F. Palin Expression of adiponectin and its receptors in swine J Anim Sci, March 1, 2005; 83(3): 565 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Penfornis and A. Marette Inducible nitric oxide synthase modulates lipolysis in adipocytes J. Lipid Res., January 1, 2005; 46(1): 135 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kudo, A. Sugawara, A. Uruno, K. Takeuchi, and S. Ito Transcription Suppression of Peroxisome Proliferator-Activated Receptor {gamma}2 Gene Expression by Tumor Necrosis Factor {alpha} via an Inhibition of CCAAT/ Enhancer-binding Protein {delta} during the Early Stage of Adipocyte Differentiation Endocrinology, November 1, 2004; 145(11): 4948 - 4956. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamaguchi, N. Omatsu, S. Matsushita, and T. Osumi CGI-58 Interacts with Perilipin and Is Localized to Lipid Droplets: POSSIBLE INVOLVEMENT OF CGI-58 MISLOCALIZATION IN CHANARIN-DORFMAN SYNDROME J. Biol. Chem., July 16, 2004; 279(29): 30490 - 30497. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Dalen, K. Schoonjans, S. M. Ulven, M. S. Weedon-Fekjaer, T. G. Bentzen, H. Koutnikova, J. Auwerx, and H. I. Nebb Adipose Tissue Expression of the Lipid Droplet-Associating Proteins S3-12 and Perilipin Is Controlled by Peroxisome Proliferator-Activated Receptor-{gamma} Diabetes, May 1, 2004; 53(5): 1243 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagai, C. Shimizu, M. Umetsu, S. Taniguchi, M. Endo, H. Miyoshi, N. Yoshioka, M. Kubo, and T. Koike Identification of a Functional Peroxisome Proliferator-Activated Receptor Responsive Element within the Murine Perilipin Gene Endocrinology, May 1, 2004; 145(5): 2346 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shimizu, A. Takeshita, T. Tsukamoto, F. J. Gonzalez, and T. Osumi Tissue-Selective, Bidirectional Regulation of PEX11{alpha} and Perilipin Genes through a Common Peroxisome Proliferator Response Element Mol. Cell. Biol., February 1, 2004; 24(3): 1313 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
J D Tugwood and C T Montague Biology and toxicology of PPARg ligands Human and Experimental Toxicology, August 1, 2002; 21(8): 429 - 437. [Abstract] [PDF] |
||||
![]() |
Y. Tamori, J. Masugi, N. Nishino, and M. Kasuga Role of Peroxisome Proliferator-Activated Receptor-{gamma} in Maintenance of the Characteristics of Mature 3T3-L1 Adipocytes Diabetes, July 1, 2002; 51(7): 2045 - 2055. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Gerhold, F. Liu, G. Jiang, Z. Li, J. Xu, M. Lu, J. R. Sachs, A. Bagchi, A. Fridman, D. J. Holder, et al. Gene Expression Profile of Adipocyte Differentiation and Its Regulation by Peroxisome Proliferator-Activated Receptor-{gamma} Agonists Endocrinology, June 1, 2002; 143(6): 2106 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mei, L. S. Holst, T. R. Landstrom, C. Holm, D. Brindley, V. Manganiello, and E. Degerman C2-Ceramide Influences the Expression and Insulin-Mediated Regulation of Cyclic Nucleotide Phosphodiesterase 3B and Lipolysis in 3T3-L1 Adipocytes Diabetes, March 1, 2002; 51(3): 631 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Souza, K. V. Muliro, L. Liscum, P. Lien, M. T. Yamamoto, J. E. Schaffer, G. E. Dallal, X. Wang, F. B. Kraemer, M. Obin, et al. Modulation of Hormone-sensitive Lipase and Protein Kinase A-mediated Lipolysis by Perilipin A in an Adenoviral Reconstituted System J. Biol. Chem., March 1, 2002; 277(10): 8267 - 8272. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. E. Floyd and J. M. Stephens Interferon-gamma -mediated Activation and Ubiquitin-Proteasome-dependent Degradation of PPARgamma in Adipocytes J. Biol. Chem., February 1, 2002; 277(6): 4062 - 4068. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iwata, T. Haruta, I. Usui, Y. Takata, A. Takano, T. Uno, J. Kawahara, E. Ueno, T. Sasaoka, O. Ishibashi, et al. Pioglitazone Ameliorates Tumor Necrosis Factor-{alpha}-Induced Insulin Resistance by a Mechanism Independent of Adipogenic Activity of Peroxisome Proliferator-Activated Receptor-{gamma} Diabetes, May 1, 2001; 50(5): 1083 - 1092. [Abstract] [Full Text] |
||||
![]() |
B. Desvergne and W. Wahli Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism Endocr. Rev., October 1, 1999; 20(5): 649 - 688. [Abstract] [Full Text] |
||||
![]() |
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hauser, G. Adelmant, P. Sarraf, H. M. Wright, E. Mueller, and B. M. Spiegelman Degradation of the Peroxisome Proliferator-activated Receptor gamma Is Linked to Ligand-dependent Activation J. Biol. Chem., June 9, 2000; 275(24): 18527 - 18533. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |